OTC · GWHP
Global WholeHealth Partners Corporation
Healthcare · Medical - Diagnostics & Research
$0.00
Down-$0.00 (-90.91%)
Updated Aug 23, 2026, 3:40 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.31K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 103.3K
- Avg. volume
- 936
Price performance
GWHP price history
1M range · 0 trading sessions · Daily adjusted prices
GWHP does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest GWHP news
The latest Smart Investors Daily articles mentioning GWHP.
Stock researchCompany · Overview
GWHP research
Overview
Company profile and research snapshot.
Company profile
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases. Global WholeHealth Partners Corporation was incorporated in 2013 and is based in San Clemente, California.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
